Journal of Endodontics
Volume 33, Issue 5 , Pages 557-560 , May 2007

In Vitro Activity of Amoxicillin, Clindamycin, Doxycycline, Metronidazole, and Moxifloxacin Against Oral Actinomyces

  • Demetrick W. LeCorn, DMD

      Affiliations

    • Department of Endodontics, College of Dentistry, and Center for Molecular Microbiology, University of Florida, Gainesville, Florida
    • ,
  • Frank J. Vertucci, DMD

      Affiliations

    • Department of Endodontics, College of Dentistry, and Center for Molecular Microbiology, University of Florida, Gainesville, Florida
    • ,
  • Maria F. Rojas, DMD

      Affiliations

    • Department of Oral Biology, College of Dentistry, and Center for Molecular Microbiology, University of Florida, Gainesville, Florida.
    • ,
  • Ann Progulske-Fox, PhD

      Affiliations

    • Department of Oral Biology, College of Dentistry, and Center for Molecular Microbiology, University of Florida, Gainesville, Florida.
    • ,
  • Myriam Bélanger, PhD

      Affiliations

    • Department of Oral Biology, College of Dentistry, and Center for Molecular Microbiology, University of Florida, Gainesville, Florida.
    • Corresponding Author InformationAddress requests for reprints to Dr. Myriam Bélanger, University of Florida, College of Dentistry, Department of Oral Biology, PO Box 100424, Gainesville, FL 32610-0424.

References 

  1. O’Grady JF, Reade PC. Periapical actinomycosis involving Actinomyces israelii. J Endod. 1988;14:147–149
  2. Xia T, Baumgartner JC. Occurrence of Actinomyces in infections of endodontic origin. J Endod. 2003;29:549–552
  3. Howell A, Stephan RM, Paul F. Prevalence of Actinomyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva. J Dent Res. 1962;41:1050–1059
  4. Chu FCS, Tsang P, Chow TW, Samaranayake LP. Identification of cultivable microorganisms from primary endodontic infections with exposed and unexposed pulp space. J Endod. 2005;31:424–429
  5. Figdor D, Davies J. Cell surface structures of Actinomyces israelii. Aust Dent J. 1997;42:125–128
  6. Tang G, Samaranayake LP, Yip HK, Chu FC, Tsang PC, Cheung BP. Direct detection of Actinomyces spp. from infected root canals in a Chinese population: a study using PCR-based, oligonucleotide-DNA hybridization technique. J Dent. 2003;31:559–568
  7. de Souza CAS, Teles RP, Souto R, Chaves MAE, Colombo APV. Endodontic therapy associated with calcium hydroxide as an intracanal dressing: microbiologic evaluation by the checkerboard DNA-DNA hybridization technique. J Endod. 2005;31:79–83
  8. Happonen RP. Periapical actinomycosis: a follow-up study of 16 surgically treated cases. Endod Dent Traumatol. 1986;2:205–209
  9. Sunde PT, Olsen I, Debelian GJ, Tronstad L. Microbiota of periapical lesions refractory to endodontic therapy. J Endod. 2002;28:304–310
  10. Byström A, Sundqvist G. Bacteriologic evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy. Scand J Dent Res. 1981;89:321–328
  11. Byström A, Sundqvist G. Bacteriologic evaluation of the effect of 0.5 percent sodium hypochlorite in endodontic therapy. Oral Surg Oral Med Oral Pathol. 1983;55:307–312
  12. Byström A, Claesson R, Sundqvist G. The antibacterial effect of camphorated paramonochlorophenol, camphorated phenol and calcium hydroxide in the treatment of infected root canals. Endod Dent Traumatol. 1985;1:170–175
  13. Orstavik D, Haapasalo M. Disinfection by endodontic irrigants and dressings of experimentally infected dentinal tubules. Endod Dent Traumatol. 1990;6:142–149
  14. Cwikla SJ, Bélanger M, Giguère S, Progulske-Fox A, Vertucci FJ. Dentinal tubule disinfection using three calcium hydroxide formulations. J Endod. 2005;31:50–52
  15. Siqueira JF. Aetiology of root canal treatment failure: why well-treated teeth can fail. Int Endod J. 2001;34:1–10
  16. Abbott PV, Hume WR, Pearman JW. Antibiotics and endodontics. Aust Dent J. 1990;35:50–60
  17. Barnard D, Davies J, Figdor D. Susceptibility of Actinomyces israelii to antibiotics, sodium hypochlorite and calcium hydroxide. Int Endod J. 1996;29:320–326
  18. Chan Y, Chan CH. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect. 2003;36:105–110
  19. Milazzo I, Blandino G, Musumeci R, Nicoletti G, Lo Bue AM, Speciale A. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents. 2002;20:451–456
  20. Behra-Miellet J, Dubreuil L, Jumas-Bilak E. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Int J Antimicrob Agents. 2002;20:366–374
  21. Dalhoff A, Petersen U, Endermann R. In vitro activity of BAY 12–8039, a new 8-methoxyquinolone. Chemotherapy. 1996;42:410–425
  22. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12–8039, gatifloxacin (AM1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother. 1997;40:639–651
  23. Speciale A, Musumeci R, Blandino G, Milazzo I, Caccamo F, Nicoletti G. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Int J Antimicrob Agents. 2002;19:111–118
  24. Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002;65:455–464
  25. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-Sixth Edition. Vol. 24, No. 2. Wayne, PA:NCCLS, 2004:M11–A6.
  26. Sundqvist G, Figdor D, Persson S, Sjögren U. Microbiologic analysis of teeth with failed endodontic treatment and the outcome of conservative re-treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:86–93
  27. Sundqvist G. Ecology of root canal flora. J Endod. 1992;18:427–430
  28. Grossman LI. Sterilization of infected root canals. J Am Dent Assoc. 1972;85:900–905
  29. Byström A, Happonen RP, Sjögren U, Sundqvist G. Healing of periapical lesions of pulpless teeth after endodontic treatment with controlled asepsis. Endod Dent Traumatol. 1987;3:58–63
  30. Appelbaum PC, Spangler SK, Jacobs MR. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother. 1990;34:1546–1550
  31. Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. 2005;56:407–409
  32. Krasemann C, Meyer J, Tillotson G. Evaluation of the clinical microbiology profile of moxifloxacin. Clin Infect Dis. 2001;32:S51–S63
  33. Tang G, Samaranayake LP, Yip HK. Molecular evaluation of residual endodontic microorganisms after instrumentation, irrigation and medication with either calcium hydroxide or Septomixine. Oral Dis. 2004;10:389–397

PII: S0099-2399(07)00100-8

doi: 10.1016/j.joen.2007.02.002

Journal of Endodontics
Volume 33, Issue 5 , Pages 557-560 , May 2007

Article Tools

* Image Usage & Resolution